Learn about current studies and see if you are eligible to enroll.
Psilocybin for Persons that Use Meth (PRIMUSS Study)
About the study: The objective of this study is to determine the safety of psilocybin in adult participants with Methamphetamine Use Disorder. (Full study details at ClinicalTrials.gov)
Participants may receive up to $595.
Eligibility Requirements: Participants who use meth, between the ages of 25-65 in the Madison and surrounding area.
How to Enroll: Complete this survey »
Psilocybin for Opioid Use Disorder (HOUDI Study)
About the Study: The primary objective of this clinical trial is to determine the safety of psilocybin in adult patients with opioid use disorder concurrently taking buprenorphine-naloxone. (Full study details at ClinicalTrials.gov)
Participants may receive up to $595.
Eligibility Requirements: participants with opioid use disorder, between the ages of 25-65 in the Madison and surrounding area..
How to Enroll: Complete this survey »
Contact Us
Megan Ringo
Program Manager
Email: Contact »
Program Office
PROTEA
UW Dept. of Family Medicine
610 N Whitney Way, STE 200
Madison, WI 53705-2700